Envestnet Portfolio Solutions Inc. Sells 1,619 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Portfolio Solutions Inc. cut its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 13,931 shares of the company’s stock after selling 1,619 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in HCA Healthcare were worth $4,476,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in HCA. Parkside Financial Bank & Trust lifted its holdings in shares of HCA Healthcare by 8.2% during the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after purchasing an additional 35 shares in the last quarter. FinTrust Capital Advisors LLC boosted its holdings in shares of HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after acquiring an additional 35 shares during the last quarter. Financial Counselors Inc. lifted its position in HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after purchasing an additional 36 shares during the period. Ballentine Partners LLC grew its position in HCA Healthcare by 1.0% in the 1st quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock worth $1,294,000 after purchasing an additional 38 shares during the period. Finally, Valley Wealth Managers Inc. lifted its holdings in shares of HCA Healthcare by 4.1% during the 4th quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock valued at $266,000 after buying an additional 39 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Insiders have sold a total of 8,844 shares of company stock worth $3,185,932 over the last ninety days. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

NYSE HCA traded down $1.15 on Thursday, reaching $370.43. The company had a trading volume of 287,215 shares, compared to its average volume of 1,148,017. The stock has a market capitalization of $97.02 billion, a PE ratio of 18.49, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The firm’s 50 day moving average price is $339.02 and its 200 day moving average price is $327.76. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $374.89.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter last year, the business posted $4.29 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 22.43 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.71%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HCA. Truist Financial increased their target price on HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a report on Wednesday, July 24th. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $329.00 to $378.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Oppenheimer raised their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research note on Thursday, May 30th. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $349.28.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.